Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 3 1

Status

Completed 7Recruiting 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 4INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 7Observational 4

Sponsor

Cancer Type

Other 2Gastrointestinal 2Lymphoid 1

Conditions

Breast Neoplasms 4997Neoplasms 4192Prostatic Neoplasms 2426Carcinoma, Non-Small-Cell Lung 2261Colorectal Neoplasms 2050Lung Neoplasms 1703Multiple Myeloma 1454Lymphoma 1403Leukemia, Myeloid, Acute 1379Neoplasm Metastasis 1372Melanoma 1269Pancreatic Neoplasms 1200Leukemia 1194Ovarian Neoplasms 1190Lymphoma, Non-Hodgkin 1128Precursor Cell Lymphoblastic Leukemia-Lymphoma 1088Head and Neck Neoplasms 1055Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 896Colonic Neoplasms 893Brain Neoplasms 875Stomach Neoplasms 854Recurrence 848Carcinoma, Hepatocellular 845Glioblastoma 837Lymphoma, Large B-Cell, Diffuse 770Rectal Neoplasms 758Uterine Cervical Neoplasms 725Carcinoma, Renal Cell 704Hodgkin Disease 696

Interventions

tocilizumab 1fish oil triglycerides 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Interventional × Colitis × Clear all
NCT05195970 2026-04-17

Walnuts and Colon Health

UConn Health

Phase NA Completed
140 enrolled
Gastrointestinal

Colitis, Feeding Behavior, Colorectal Neoplasms

NCT03601611 2020-04-21

COLAR

Herlev Hospital

Phase NA Completed
20 enrolled

Arthritis, Colitis

NCT03548948 2019-09-27

Obesity, Iron Regulation and Colorectal Cancer Risk

University of Illinois at Chicago

Phase NA Completed
17 enrolled
Other

Colitis, Obesity

NCT00518349 2018-05-29

Colonoscope Passive Bending Function

Norwegian Department of Health and Social Affairs

Phase NA Completed
120 enrolled 6 charts
Gastrointestinal

Adenoma, Carcinoma, Colitis, Colonic Diseases, Functional

NCT01369329 2016-12-07

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Janssen Research & Development, LLC

Phase 3 Completed
769 enrolled 13 charts

Colitis, Crohn Disease, Inflammatory Bowel Diseases

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed
14 enrolled
Other

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Prometheus Laboratories

Phase 2 Completed
190 enrolled
Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡